Login / Signup

Cardiovascular safety of dihydroergotamine mesylate delivered by precision olfactory delivery (INP104) for the acute treatment of migraine.

Rima M DaferGretchen E TietjenJohn F RothrockRobert E VannStephen B ShrewsburySheena K Aurora
Published in: Headache (2024)
In two separate studies, INP104 demonstrated a favorable CV safety profile when used in a study population without CV-related contraindications.
Keyphrases
  • liver failure
  • drug induced
  • respiratory failure
  • aortic dissection
  • intensive care unit
  • replacement therapy
  • mechanical ventilation